• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of Body Mass Index With Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis.腹膜透析患者体重指数与死亡率的关联:一项系统评价和荟萃分析。
Perit Dial Int. 2016 May-Jun;36(3):315-25. doi: 10.3747/pdi.2015.00052. Epub 2015 Oct 16.
2
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
8
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
9
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
10
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.

引用本文的文献

1
Correlation of the triglyceride-glucose-body mass index with all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study.甘油三酯-血糖-体重指数与腹膜透析患者全因死亡率和心血管死亡率的相关性:一项回顾性队列研究
Front Nutr. 2025 Aug 20;12:1612402. doi: 10.3389/fnut.2025.1612402. eCollection 2025.
2
The association between body mass index and mortality in diabetic patients with end-stage renal disease is different in hemodialysis and peritoneal dialysis.在糖尿病终末期肾病患者中,体重指数与死亡率之间的关联在血液透析和腹膜透析患者中有所不同。
Ren Fail. 2025 Dec;47(1):2510549. doi: 10.1080/0886022X.2025.2510549. Epub 2025 May 29.
3
Impact of obesity on in-hospital outcomes in peritoneal dialysis patients: insights from a nationwide analysis.肥胖对腹膜透析患者住院结局的影响:一项全国性分析的见解
Int Urol Nephrol. 2025 Feb 28. doi: 10.1007/s11255-025-04438-w.
4
Associations between different insulin resistance indices and the risk of all-cause mortality in peritoneal dialysis patients.不同胰岛素抵抗指数与腹膜透析患者全因死亡率的关系。
Lipids Health Dis. 2024 Sep 7;23(1):287. doi: 10.1186/s12944-024-02275-x.
5
The effect of body mass index on mortality, peritonitis, technique proficiency and residual renal function in peritoneal dialysis patients.体重指数对腹膜透析患者死亡率、腹膜炎、技术熟练程度和残余肾功能的影响。
Int Urol Nephrol. 2024 Jul;56(7):2379-2389. doi: 10.1007/s11255-024-03988-9. Epub 2024 Mar 2.
6
Effects of oral nutritional supplements on the nutritional status and inflammatory markers in patients on maintenance dialysis: a systematic review and meta-analysis of randomized clinical trials.口服营养补充剂对维持性透析患者营养状况和炎症标志物的影响:一项随机临床试验的系统评价和荟萃分析
Clin Kidney J. 2023 May 27;16(11):2271-2288. doi: 10.1093/ckj/sfad130. eCollection 2023 Nov.
7
Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis.腹膜透析中的肥胖、体重增加和液体超负荷
Front Nephrol. 2022 Jun 28;2:880097. doi: 10.3389/fneph.2022.880097. eCollection 2022.
8
Impact of Weight Gain on the Subsequent Survival of New Peritoneal Dialysis Patients.体重增加对新腹膜透析患者后续生存的影响。
Kidney Dis (Basel). 2023 Jan 17;9(3):197-205. doi: 10.1159/000529186. eCollection 2023 May.
9
Elevated Ferritin Levels Associated with High Body Fat Mass Affect Mortality in Peritoneal Dialysis Patients.铁蛋白水平升高与体脂肪量高相关,影响腹膜透析患者的死亡率。
Nutrients. 2023 Apr 29;15(9):2149. doi: 10.3390/nu15092149.
10
Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.社区居住老年人肌少症的相关因素:系统评价和荟萃分析。
Nutrients. 2021 Nov 27;13(12):4291. doi: 10.3390/nu13124291.

本文引用的文献

1
The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients.中风中的肥胖悖论:肥胖中风患者的死亡率较低且复发性中风再入院风险较低。
Int J Stroke. 2015 Jan;10(1):99-104. doi: 10.1111/ijs.12016.
2
Obesity paradox in end-stage kidney disease patients.终末期肾病患者的肥胖悖论。
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):415-25. doi: 10.1016/j.pcad.2013.10.005. Epub 2013 Oct 9.
3
Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients.亚洲与白种人和非裔美国人血液透析患者的身体大小和肌肉质量替代物的死亡率预测性。
Mayo Clin Proc. 2013 May;88(5):479-86. doi: 10.1016/j.mayocp.2013.01.025. Epub 2013 Apr 4.
4
Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study.巴西腹膜透析多中心研究中,起始腹膜透析患者的体表面积和纵向体重变化不会增加死亡率。
Clinics (Sao Paulo). 2013 Jan;68(1):51-8. doi: 10.6061/clinics/2013(01)oa08.
5
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.利用身体成分替代指标预测死亡率:采用综合排序评分分析检查血液透析患者的肥胖悖论。
Am J Epidemiol. 2012 Apr 15;175(8):793-803. doi: 10.1093/aje/kwr384. Epub 2012 Mar 16.
6
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.接受血液透析患者的肥胖悖论和与身体大小及肌肉质量替代指标相关的死亡率。
Mayo Clin Proc. 2010 Nov;85(11):991-1001. doi: 10.4065/mcp.2010.0336.
7
Relationship between body mass index and mortality in adults on maintenance hemodialysis: a systematic review.维持性血液透析成人的体重指数与死亡率的关系:系统评价。
J Ren Nutr. 2010 Sep;20(5):281-292, 7 p following 292. doi: 10.1053/j.jrn.2010.03.010. Epub 2010 Jun 26.
8
Cardiovascular risk in the peritoneal dialysis patient.腹膜透析患者的心血管风险。
Nat Rev Nephrol. 2010 Aug;6(8):451-60. doi: 10.1038/nrneph.2010.68. Epub 2010 Jun 22.
9
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.估算肾小球滤过率和白蛋白尿与普通人群全因和心血管死亡率的关系:荟萃分析协作研究。
Lancet. 2010 Jun 12;375(9731):2073-81. doi: 10.1016/S0140-6736(10)60674-5. Epub 2010 May 17.
10
Technique failure in peritoneal dialysis patients: insights and challenges.腹膜透析患者的技术失败:见解与挑战。
Perit Dial Int. 2010 Mar-Apr;30(2):161-2. doi: 10.3747/pdi.2010.00020.

腹膜透析患者体重指数与死亡率的关联:一项系统评价和荟萃分析。

Association of Body Mass Index With Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis.

作者信息

Ahmadi Seyed-Foad, Zahmatkesh Golara, Streja Elani, Mehrotra Rajnish, Rhee Connie M, Kovesdy Csaba P, Gillen Daniel L, Ahmadi Emad, Fonarow Gregg C, Kalantar-Zadeh Kamyar

机构信息

Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California, USA Department of Population Health and Disease Prevention, Program in Public Health, University of California Irvine, Irvine, California, USA.

Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California, USA.

出版信息

Perit Dial Int. 2016 May-Jun;36(3):315-25. doi: 10.3747/pdi.2015.00052. Epub 2015 Oct 16.

DOI:
10.3747/pdi.2015.00052
PMID:26475847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4881795/
Abstract

UNLABELLED

♦

BACKGROUND

Although higher body mass index (BMI) is associated with better outcomes in hemodialysis patients, the relationship in peritoneal dialysis (PD) patients is less clear. We aimed to synthesize the results from all large and high-quality studies to examine whether underweight, overweight, or obesity is associated with any significantly different risk of death in peritoneal dialysis patients. ♦

METHODS

We searched MEDLINE, EMBASE, Web of Science, CINAHL, and Cochrane CENTRAL, and screened 7,123 retrieved studies for inclusion. Two investigators independently selected the studies using predefined criteria and assessed each study's quality using the Newcastle-Ottawa Quality Assessment Scale. We meta-analyzed the results of the largest studies with no overlap in their data sources. ♦

RESULTS

We included 9 studies (n = 156,562) in the systematic review and 4 studies in the meta-analyses. When examined without stratifying studies by follow-up duration, the results of the studies were inconsistent. Hence, we pooled the study results stratified based upon their follow-up durations, as suggested by a large study, and observed that being underweight was associated with higher 1-year mortality but had no significant association with 2- and 3- to 5-year mortalities. In contrast, being overweight or obese was associated with lower 1-year mortality but it had no significant association with 2-, and 3- to 5-year mortalities. ♦

CONCLUSION

Over the short-term, being underweight was associated with higher mortality and being overweight or obese was associated with lower mortality. The associations of body mass with mortality were not significant over the long-term.

摘要

未标注

♦

背景

虽然较高的体重指数(BMI)与血液透析患者更好的预后相关,但在腹膜透析(PD)患者中的关系尚不清楚。我们旨在综合所有大型高质量研究的结果,以检验体重过轻、超重或肥胖是否与腹膜透析患者任何显著不同的死亡风险相关。♦

方法

我们检索了MEDLINE、EMBASE、科学网、护理学与健康领域数据库(CINAHL)和Cochrane中心对照试验注册库,并筛选了检索到的7123项研究以纳入分析。两名研究者使用预定义标准独立选择研究,并使用纽卡斯尔-渥太华质量评估量表评估每项研究的质量。我们对数据来源无重叠的最大规模研究结果进行了荟萃分析。♦

结果

我们在系统评价中纳入了9项研究(n = 156,562),在荟萃分析中纳入了4项研究。在不按随访时间分层研究的情况下进行检验时,研究结果不一致。因此,我们按照一项大型研究的建议,汇总了根据随访时间分层的研究结果,观察到体重过轻与1年死亡率较高相关,但与2年以及3至5年死亡率无显著关联。相比之下,超重或肥胖与1年死亡率较低相关,但与2年以及3至5年死亡率无显著关联。♦

结论

短期内,体重过轻与较高死亡率相关,超重或肥胖与较低死亡率相关。从长期来看,体重与死亡率之间的关联并不显著。